News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Peter Fellner To Become New Chairman Of Acambis
July 12, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Acambis plc (“Acambis') (LSE: ACM, NASDAQ: ACAM) announces that, effective from 1 October 2006, Alan Smith will retire as Chairman, and from the Board, of Acambis and will be succeeded by Dr Peter Fellner.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Layoff Tracker
Cuts at Merck, Disc Leave Hundreds Jobless
March 2, 2026
·
60 min read
·
BioSpace Editorial Staff
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
·
5 min read
·
Tristan Manalac
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
·
2 min read
·
Annalee Armstrong
Deals
Boehringer Seeks To Rebalance Immunity With Sitryx Collab Potentially Worth $500M+
February 26, 2026
·
1 min read
·
Tristan Manalac
